Strategic partnerships Cardiomatics actively collaborates with physicians, Holter device manufacturers, and global providers, and has a history of partnerships with Arseus Medical and BIOTRONIK. Leverage these relationships to position integrated AI-driven ECG analysis as a value-add for existing distribution channels and co-marketing opportunities.

Clinical leadership The company is invited to keynote at major cardiovascular events such as ESC Congress 2026, highlighting thought leadership and credibility. Use this prestige to open C-suite conversations with hospitals and health systems seeking innovative AI-enabled workflows and trusted diagnostic reports.

Regulatory tech edge A cloud-based AI medical-grade system emphasizes accuracy and trust for faster, clearer reports and better workflows. Target healthcare providers prioritizing compliant, scalable cloud solutions to streamline ECG analysis and reduce interpretive variability.

Growth signals Revenue is in the low-to-mid millions with established seed funding and multiple funding rounds, indicating investor confidence and a scale-up trajectory. Approach strategic buyers and PE/VC-backed healthtech consolidations with expansion-ready product capabilities and customer success motions.

Global expansion Global partnerships and appearances at international events point to a multi-market go-to-market. Propose tiered regional deployments, localized support, and channel partnerships to accelerate adoption in Europe, North America, and other key markets.